AU699912B2 - (Vibrio cholerae) 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains and methods of making same - Google Patents

(Vibrio cholerae) 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains and methods of making same Download PDF

Info

Publication number
AU699912B2
AU699912B2 AU79714/94A AU7971494A AU699912B2 AU 699912 B2 AU699912 B2 AU 699912B2 AU 79714/94 A AU79714/94 A AU 79714/94A AU 7971494 A AU7971494 A AU 7971494A AU 699912 B2 AU699912 B2 AU 699912B2
Authority
AU
Australia
Prior art keywords
cholerae
plasmid
sequences
strain
cholera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU79714/94A
Other languages
English (en)
Other versions
AU7971494A (en
Inventor
James B. Kaper
Myron M. Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Publication of AU7971494A publication Critical patent/AU7971494A/en
Application granted granted Critical
Publication of AU699912B2 publication Critical patent/AU699912B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU79714/94A 1993-10-08 1994-10-07 (Vibrio cholerae) 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains and methods of making same Ceased AU699912B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13343893A 1993-10-08 1993-10-08
US13343993A 1993-10-08 1993-10-08
US08/133438 1993-10-08
US08/133439 1993-10-08
PCT/US1994/011424 WO1995010300A1 (en) 1993-10-08 1994-10-07 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains and methods of making same

Publications (2)

Publication Number Publication Date
AU7971494A AU7971494A (en) 1995-05-04
AU699912B2 true AU699912B2 (en) 1998-12-17

Family

ID=26831377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79714/94A Ceased AU699912B2 (en) 1993-10-08 1994-10-07 (Vibrio cholerae) 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains and methods of making same

Country Status (8)

Country Link
EP (1) EP0722339A4 (ru)
JP (1) JP3379582B2 (ru)
KR (1) KR100348156B1 (ru)
CN (1) CN1104907C (ru)
AU (1) AU699912B2 (ru)
CA (1) CA2173606A1 (ru)
RU (1) RU2140981C1 (ru)
WO (1) WO1995010300A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0887403A3 (en) * 1997-06-27 2000-12-06 Chiron S.P.A. Attenuated Vibrio cholerae strains
EP0928831B1 (en) * 1997-12-10 2006-05-03 Council of Scientific and Industrial Research Cholera organisms, vaccines and preparation thereof
CN111826316A (zh) * 2020-07-28 2020-10-27 上海海洋大学 耐受重金属的非o1/o139型霍乱弧菌菌株及应用
CN111662855A (zh) * 2020-07-28 2020-09-15 上海海洋大学 耐受抗菌素和重金属的非o1/o139型霍乱弧菌菌株及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU656730B2 (en) * 1990-06-05 1995-02-16 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof
JP4179627B2 (ja) * 1992-07-06 2008-11-12 プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ コレラワクチンとしての欠失変異体

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MICHALSKI ET AL INFECTION & IMMUNITY 61(10) P 4462-68 1993 *
TACKET ET AL J INFECTIOUS DISEASES 168(6) P 1536-40 1993 *

Also Published As

Publication number Publication date
AU7971494A (en) 1995-05-04
EP0722339A1 (en) 1996-07-24
CA2173606A1 (en) 1995-04-20
WO1995010300A1 (en) 1995-04-20
CN1142774A (zh) 1997-02-12
KR960704571A (ko) 1996-10-09
EP0722339A4 (en) 2001-05-23
RU2140981C1 (ru) 1999-11-10
KR100348156B1 (ko) 2003-01-06
JP3379582B2 (ja) 2003-02-24
CN1104907C (zh) 2003-04-09
JPH09504430A (ja) 1997-05-06

Similar Documents

Publication Publication Date Title
US5399494A (en) Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom
US5631010A (en) Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1
Kaper et al. Toxins of Vibrio cholerae
Guidolin et al. Genetics of Vibrio cholerae and its bacteriophages
Michalski et al. CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain
Butterton et al. Heterologous antigen expression in Vibrio cholerae vector strains
AU763683B2 (en) Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines
US4935364A (en) Method of isolating restriction fragment deletions in vibrio cholerae and products thereof
EP0119031B1 (en) Avirulent Vibrio Cholerae and methods for its production
US5882653A (en) Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof
US5874088A (en) Deletion mutants of cholera vaccines expressing heterologous antigens
EP0485591B1 (en) Method for isolating deletion mutants of vibrio cholerae and cultures containing vibrio cholerae
AU699912B2 (en) (Vibrio cholerae) 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains and methods of making same
US5470729A (en) Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
US5783196A (en) Gua mutants of shigella spp. and vaccines containing the same
Levine et al. 5.1 AN OVERVIEW OF CHOLERA PATHOGENESIS
EP0717774A1 (en) Production of gonorrheal pi proteins and vaccines in e. coli and salmonella
JPH0630569B2 (ja) 遺伝子工学的に作成された無毒性Ｖｉｂｒｉｏ ｃｈｏｌｅｒａｅ、その用途及びその製造方法